Organic Compounds

Robin Alec Fairhurst; Rebecca Butler; Paul Oakley; Stephen Paul Collingwood; Nichola Smith; Emily Stanley; Maria Ines Rodriguez Perez

Organic Compounds

Robin Alec Fairhurst (Inventor), Rebecca Butler (Inventor), Paul Oakley (Inventor), Stephen Paul Collingwood (Inventor), Nichola Smith (Inventor), Emily Stanley (Inventor), Maria Ines Rodriguez Perez (Inventor)

Novartis International AG

Research output: Patent

Abstract

A compound of formula (I), or tautomers, or stereoisomers, or solvates, or pharmaceutically acceptable salts thereof, wherein M1, M2, L1, L2, W1, W2, X1, X2, Y1, Y2, A, R and R are as defined herein for the for treatment of conditions treatable by the blockade of an epithelial sodium channel, particularly conditions benefiting from mucosal hydration.

Original language	English
Patent number	WO2008135557A1
IPC	C07D 401/14
Priority date	7/05/07
Filing date	5/05/08
Publication status	Published - 13 Nov 2008
Externally published	Yes

Cite this

@misc{18726dab6a504c0483deadec36205380,

title = "Organic Compounds",

abstract = "A compound of formula (I), or tautomers, or stereoisomers, or solvates, or pharmaceutically acceptable salts thereof, wherein M1, M2, L1, L2, W1, W2, X1, X2, Y1, Y2, A, R and R are as defined herein for the for treatment of conditions treatable by the blockade of an epithelial sodium channel, particularly conditions benefiting from mucosal hydration.",

author = "Fairhurst, {Robin Alec} and Rebecca Butler and Paul Oakley and Collingwood, {Stephen Paul} and Nichola Smith and Emily Stanley and {Rodriguez Perez}, {Maria Ines}",

year = "2008",

month = nov,

day = "13",

language = "English",

type = "Patent",

note = "WO2008135557A1; C07D 401/14 ",

}

TY - PAT

T1 - Organic Compounds

AU - Fairhurst, Robin Alec

AU - Butler, Rebecca

AU - Oakley, Paul

AU - Collingwood, Stephen Paul

AU - Smith, Nichola

AU - Stanley, Emily

AU - Rodriguez Perez, Maria Ines

PY - 2008/11/13

Y1 - 2008/11/13

N2 - A compound of formula (I), or tautomers, or stereoisomers, or solvates, or pharmaceutically acceptable salts thereof, wherein M1, M2, L1, L2, W1, W2, X1, X2, Y1, Y2, A, R and R are as defined herein for the for treatment of conditions treatable by the blockade of an epithelial sodium channel, particularly conditions benefiting from mucosal hydration.

AB - A compound of formula (I), or tautomers, or stereoisomers, or solvates, or pharmaceutically acceptable salts thereof, wherein M1, M2, L1, L2, W1, W2, X1, X2, Y1, Y2, A, R and R are as defined herein for the for treatment of conditions treatable by the blockade of an epithelial sodium channel, particularly conditions benefiting from mucosal hydration.

UR - https://worldwide.espacenet.com/patent/search/family/038581916/publication/WO2008135557A1?q=WO2008135557

M3 - Patent

M1 - WO2008135557A1

Y2 - 2008/05/05

ER -

Organic Compounds

Abstract

Other files and links

Fingerprint

Cite this